Skip to main content
OpenTrials
Completed

NCT Number: NCT00402311

The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients

The purpose of this study is to determine the effects and cost-effectiveness of a Diagnostic Observation Center for PsychoGeriatric patients (DOC-PG). Our main hypothesis is that DOC-PG has added value compared with usual care regarding Health Related Quality of Life (HRQoL).

Completed

Looking for future studies?

Notify Me

Key information

Age range

55 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Academic Hospital Maastricht

Maastricht, Limburg, 6202 AZ, Netherlands

About this study

An integrated multidisciplinary approach to diagnosing and managing dementia is generally recommended, though rarely investigated. In recent years, multidisciplinary memory clinics (MCs) for patients with dementia have been established in many places over the world. These services have recently also been criticised for being principally hospital-based, for their apparently limited focus that entails only medical diagnostics and pharmacotherapy and for thus diverting resources from community mental health teams(CMHTs) .On the other hand, CMHTs are mainly concerned with the provision and organisation of integrated care, and unlike MCs, CMHTs generally have limited access to hospital-based diagnostics such as brain-imaging.

In April 2002, an outpatient diagnostic facility, the Diagnostic Observation Centre for PsychoGeriatric patients (DOC-PG) was established in Maastricht, the Netherlands. DOC-PG combines the hospital-based approach of the MC with the care-oriented approach of the regional CMHT and aims to provide the general practitioner (GP) with elaborate diagnostic and therapeutic advice for patients with cognitive disorders.

Comparison: DOC-PG is compared with usual care i.e. the GP took care of the diagnosis, or he or she referred the patient to one of the separate regional services, e.g. the Maastricht Memory Clinic (MMC), geriatric medicine, or the department of mental health for the elderly of the mental health community service (CMHT).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 55 years or over
  • Suspected of having dementia or combined somatic/psychiatric disorder
  • No referral to other local/regional services in the last two years
  • Availability of a proxy (visiting the patient at least once a week)

Exclusion criteria

  • Acute disorders that need a prompt therapeutic intervention
  • Living in a nursing home or receiving care that is comparable to that of a nursing home

Treatment and study plan

DOC-PG: integrated multidisciplinary assessment

Procedure

Usual care: assessment by GP or one of the regional services

Procedure

Primary outcomes

  1. The Visual Analogue Scale of the EuroQol-5D

Secondary outcomes

  1. Utility score of the EuroQol-5D

  2. Short Form 36 (SF-36)

  3. Mini Mental State Examination (MMSE)

  4. Global Deterioration Scale (GDS)

  5. NeuroPsychiatric Inventory (NPI)

  6. Instrumental Activities of Daily Living scale (IADL)

  7. Cornell Scale of Depression in Dementia (CSDD)

  8. Perceived Pressure from Informal Care (Dutch translation, EDIZ)

  9. Informal care questionnaire

Sponsors and collaborators

Lead sponsor

Maastricht University Medical Center

Other

Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

Registry information

Official study title

A Prospective Randomized Trial on the Effects of a Psychogeriatric Diagnostic Day Hospital

Important dates

Study start
2002
Study completion
2005
First posted
Nov 22, 2006
Registry last updated
Jan 22, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.